Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted

NCT02656875 is registered in ClinicalTrials.gov with Trevena Inc. as lead sponsor.

NCT NCT02656875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02656875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute Pain for Which Parenteral Opioid Therapy is Warranted
Lead sponsor
Trevena Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2015
Completion date
August 31, 2017
Enrollment
768 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

acute pain